Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02003053 · ClinicalTrials.gov registry record · NA

A Randomized, Controlled Trial of Inspiratory Muscle Training (IMT)in the ICU and CCU

A NA study of Respiratory Failure and Critically Ill, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
7
Enrollment target
1
Study location

NCT02003053: Completed NA study of Respiratory Failure and Critically Ill, sponsored by Wake Forest University Health Sciences.

NCT02003053 is a NA study of Respiratory Failure and Critically Ill that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 7 participants, below the 4,524-participant average among 40 other Respiratory Failure trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02003053, a NA study of Respiratory Failure and Critically Ill, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
7 participants
Enrollment target
1
Study location

Study Summary

Inspiratory muscle training (IMT) is an intervention used with success in the outpatient setting within the COPD population. Use of IMT is also theoretically possible during mechanical ventilation. This study will will assess the feasibility and safety of the study of IMT in the patient population.

Primary Outcome

The number of patients tolerating Inspiratory Muscle Training or Sham.

Interventions

  • DEVICE Inspiratory Muscle Trainer

Study Locations (1)

North Carolina

  • Wake Forest Baptist Medical Center - Winston-Salem

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2013-04
Est. Completion 2015-12
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT02003053 record still lists

NCT02003053 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 4,524-participant average among 40 other Respiratory Failure trials with a reported enrollment target (100% lower).

The record links to 2 conditions, with Respiratory Failure appearing as the primary indexed condition, and to 1 intervention - of which Inspiratory Muscle Trainer is the first listed.

NCT02003053 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT02003053 about?

NCT02003053 is a clinical study titled "A Randomized, Controlled Trial of Inspiratory Muscle Training (IMT)in the ICU and CCU". Inspiratory muscle training (IMT) is an intervention used with success in the outpatient setting within the COPD population. Use of IMT is also theoretically possible during mechanical ventilation. This study will will assess the feasibility and safety of the study of IMT in the patient population.

What is the current status of trial NCT02003053?

This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2013-04. Estimated completion is 2015-12.

What conditions does trial NCT02003053 study?

This clinical trial studies the following conditions: Respiratory Failure, Critically Ill.

What interventions are being tested in trial NCT02003053?

The interventions under investigation include: Inspiratory Muscle Trainer (DEVICE).

Who is sponsoring clinical trial NCT02003053?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02003053 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Respiratory Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02003053's enrollment target sits among peer trials

7 41st of 40 the lowest of 40 other Respiratory Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Respiratory Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02003053, the US trial registry maintained by the National Library of Medicine. NCT02003053 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.